Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03777384 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

EValuating the Safety Of De-escaLated Head and Neck Irradiation in HPV positivE Oropharynx Cancer in Non-smokers/Minimal Smokers

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 6, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Study Identification, Study Status, Oversightv10
  2. Primary completion date: Jul 2024 to Jul 2026
    • Study completion date: Dec 2025 to Dec 2026
    v9
  3. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 60 to confirmed 75
    • Site details revised at 2 of 2 sites
    v8
  4. Primary completion date: Jul 2023 to Jul 2024
    • Study completion date: Dec 2023 to Dec 2025
    v7
  5. Primary completion date: Jul 2022 to Jul 2023v6
Show 4 earlier versionsHide 4 earlier versions
  1. Enrollment target: 20 to 60
    • Site contacts updated at 1 of 2 sites
    v5
  2. Primary completion date: Jul 2020 to Jul 2022v4
  3. Primary completion date: Dec 2019 to Jul 2020v3
  4. Trial status: Active, Not Recruiting to Recruiting
    • Primary endpoint revised
    • Site details revised at 2 of 2 sites
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A prospective, observational study evaluating the durability of local/regional control of previously published de-escalated radiotherapy protocols for patients with P16 positive oropharynx cancers who have minimal nicotine exposure who are not current uses (\< 10 pack year smoking history; \< 10 year history of any nicotine product \[electronic cigarette, chewing tobacco\]). Quality of Life measures will also be collected.
Trial Details
NCT Number NCT03777384
Lead Sponsor Sanford Health
Conditions
(from sponsor)		 Oropharyngeal Cancer
Related terms Head and Neck Neoplasms, Oropharyngeal Neoplasms
Enrollment 75 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov